Track topics on Twitter Track topics that are important to you
Austin—Two years after gaining FDA approval to market a minimally invasive gastrointestinal balloon to combat obesity, Apollo Endosurgery (NASDAQ: APEN) is now dealing with fallout from patient deaths following implantations of the device. In a letter to healthcare providers dated Aug. 10, the FDA stated that seven deaths occurred in patients with liquid-filled intragastric balloon […]
Original Article: Austin’s Apollo Endosurgery Responds to FDA Note After Patient DeathsNEXT ARTICLE
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...
Diabetes Diabetes Endocrine Obesity Oxycontin Renal Disease Thyroid Disorders Endocrinology is the study of the endocrine glands and the hormones that they secrete (Oxford Medical Dictionary). There are several groups of h...